Content deleted Content added
See my talk page edits of related cannabinoids for extensive legal breakdowns of related compounds. |
m Added UNII |
||
Line 24: | Line 24: | ||
<!--Identifiers--> |
<!--Identifiers--> |
||
⚫ | |||
| CAS_number = 1400742-15-5 |
| CAS_number = 1400742-15-5 |
||
⚫ | |||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = 3N1P3KD3CV |
|||
| ATC_prefix = |
| ATC_prefix = |
||
| ATC_suffix = |
| ATC_suffix = |
Revision as of 16:20, 25 January 2021
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C22H27N3O |
Molar mass | 349.478 g·mol−1 |
3D model (JSmol) | |
| |
|
CUMYL-PINACA (also known as SGT-24) is an indazole-3-carboxamide based synthetic cannabinoid. CUMYL-PINACA acts as a potent agonist for the cannabinoid receptors, with approximately 3x selectivity for CB1, having an EC50 of 0.15nM for human CB1 receptors and 0.41nM for human CB2 receptors.[1]
Legal status
Sweden's public health agency suggested classifying CUMYL-PINACA as a hazardous substance, on November 10, 2014.[2]
See also
References
- ^ Dobaja M, Grenc D, Kozelj G, Brvar M (March 2017). "Occupational transdermal poisoning with synthetic cannabinoid cumyl-PINACA". Clinical Toxicology. 55 (3): 193–195. doi:10.1080/15563650.2016.1278224. PMID 28084855. S2CID 21304629.
- ^ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Retrieved 11 July 2015.